Blood money : the story of life, death, and profit inside America's blood industry
(Book)

Includes bibliographical references (pages 195-215) and index.

Every year, about twenty million Americans sell blood plasma for cash in a barely regulated market dominated by private industry and off-the-grid trafficking. These commercial efforts prey on an insatiable market for medical and scientific innovation fed from the veins of some of the country's most marginalized communities, such as undocumented immigrants and residents of poverty-stricken Flint, Michigan. We are often told that "blood donations" are used to save lives, but blood plasma, a component of whole blood, has become a precious commercial good. Blood plasma is collected and marketed by private industry, with the United States one of just five nations on the planet that have not yet banned the practice of pay-for-plasma giving. This precious resource is used for everything from expensive and unprovenage-reversing treatments to costly and experimental cures for novel diseases like COVID-19. Based on a cross-country investigation into the plasma-giving capitals of the country, in-depth research into the blood industry, and her personal experience as abeneficiary of plasma-derived treatment for a rare condition, Kathleen McLaughlin's Blood Money reveals the underhanded machinations and unbalanced power structures of the blood industry. Taking us from China's blood black market to Silicon Valley's shadowy tech startups, this is an unforgettable inside look at an industry many of us had no idea even existed. Blood Money is an electrifying exposae that demonstrates the shadowy overlap between big medicine and big business and paints a searing portrait ofthe extent to which American industry feeds on the country's most vulnerable.